关注
Ashna Talwar, Ph.D
Ashna Talwar, Ph.D
MedImpact Healthcare Systems, University of Houston
在 central.uh.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Application of machine learning in predicting hospital readmissions: a scoping review of the literature
Y Huang, A Talwar, S Chatterjee, RR Aparasu
BMC medical research methodology 21, 1-14, 2021
742021
Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis
A Talwar, E Estes, R Aparasu, DS Reddy
Experimental Neurology 359, 114238, 2023
292023
Fondaparinux Sodium Compared With Low‐Molecular‐Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta‐analysis
A Kumar, A Talwar, JF Farley, J Muzumdar, JC Schommer, R Balkrishnan, ...
Journal of the American Heart Association 8 (10), e012184, 2019
222019
Anticholinergic medications and risk of dementia in older adults: Where are we now?
S Chatterjee, A Talwar, RR Aparasu
Expert Opinion on Drug Safety 19 (10), 1251-1267, 2020
212020
Machine learning methods to predict 30-day hospital readmission outcome among US adults with pneumonia: analysis of the national readmission database
Y Huang, A Talwar, Y Lin, RR Aparasu
BMC Medical Informatics and Decision Making 22 (1), 288, 2022
52022
Prescribing of disease modifying agents in older adults with multiple sclerosis
A Talwar, JR Earla, GJ Hutton, RR Aparasu
Multiple Sclerosis and Related Disorders 57, 103308, 2022
42022
Performance of advanced machine learning algorithms overlogistic regression in predicting hospital readmissions: A meta-analysis
A Talwar, MA Lopez-Olivo, Y Huang, L Ying, RR Aparasu
Exploratory Research in Clinical and Social Pharmacy 11, 100317, 2023
32023
Pain management practices for outpatients with breast cancer
A Talwar, S Rege, RR Aparasu
Exploratory Research in Clinical and Social Pharmacy 6, 100155, 2022
32022
Differences in perceived threat and efficacy in managing opioid use disorder versus alcohol use disorder
V Tata, Z Majd, A Talwar, S Bapat, ADL Cruz, JE Essien, JD Thornton
Substance Use & Misuse 58 (10), 1187-1195, 2023
22023
PSU20 Predicting readmissions for Elective hip and knee arthroplasty in adults using machine learning algorithms
A Talwar, Y Huang, Y Lin, P Masurkar, RR Aparasu
Value in Health 24, S227-S228, 2021
12021
Pdg44 drug information on the internet-consistently inconsistent results: content analysis using three major search engines
Z Majd, A Talwar, SS Sansgiry
Value in Health 22, S169-S170, 2019
12019
Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer’s Disease Initiating Cholinesterase Inhibitors
A Talwar, S Chatterjee, J Sherer, S Abughosh, M Johnson, RR Aparasu
Drugs & Aging 41 (4), 339-355, 2024
2024
CUMULATIVE ANTICHOLINERGIC BURDEN AND ASSOCIATED OUTCOMES AMONG OLDER ADULTS WITH ALZHEIMER’S DISEASE
A TALWAR
2024
EE483 Health Care Expenditures for Substance Use Disorders: A Comparative National Study
Z Zeng, A Talwar, RR Aparasu
Value in Health 26 (6), S147-S148, 2023
2023
EE496 Comparative Healthcare Burden for Colorectal Cancer and Other Cancers: Medical Expenditure Panel Survey Study
S Yazdanfard, A Talwar, RR Aparasu
Value in Health 26 (6), S150, 2023
2023
CO203 Cumulative Anticholinergic Burden and Its Predictors Among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors
A Talwar, JT Sherer, S Abughosh, S Chatterjee, ML Johnson, RR Aparasu
Value in Health 26 (6), S53, 2023
2023
Cost-effectiveness analysis of abemaciclib and endocrine therapy combination for the adjuvant treatment of HR+/HER2-, node-positive, high-risk, early breast cancer
A Talwar, A Deshmukh, M Trivedi, RR Aparasu
Cancer Research 83 (7_Supplement), 4364-4364, 2023
2023
Anticholinergic medications and risk of dementia in older adults: A meta-analysis of recent literature
A Talwar, S Chatterjee, MA Lopez-Olivo, RR Aparasu
Research in Social and Administrative Pharmacy 19 (3), 3, 2023
2023
EPH110 Endocrine Therapy and Risk of Dementia in Patients with Breast Cancer: A Systematic Review
BL Christensen, A Talwar, RR Aparasu
Value in Health 25 (7), S455, 2022
2022
Factors associated with different dosage forms of disease-modifying agents in older adults with multiple sclerosis
A Talwar, JR Earla, GJ Hutton, RR Aparasu
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 228-228, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20